ÑÇÐÇÓÎÏ·¹ÙÍø-www.yaxin868.com

  • ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾Ï³´²¹Ù·½ÍøÕ¾½ñÌìÊÇ£º2025-06-06Çл»³ÇÊÐ[È«¹ú]-ÍøÕ¾µØÍ¼
    ÍÆ¼ö²úÆ· :
    ÍÆ¼öÐÂÎÅ
    ¼¼ÊõÎÄÕµ±Ç°Î»ÖÃ:¼¼ÊõÎÄÕÂ>

    Ò»ÖÖ¼ì²âÊÜʵÑéÕßÌåÒºÌåÍâ´Ù½ø¼²²¡Ïà¹Øµ°°×Á×ËữÐÞÊÎÄÜÁ¦µÄ·½·¨

    ʱ¼ä:2023-06-14    ×÷Õß: ¹ÜÀíÔ±

    Ò»ÖÖ¼ì²âÊÜʵÑéÕßÌåÒºÌåÍâ´Ù½ø¼²²¡Ïà¹Øµ°°×Á×ËữÐÞÊÎÄÜÁ¦µÄ·½·¨
    ¡¾×¨ÀûÕªÒª¡¿±¾·¢Ã÷Éæ¼°Ò»ÖÖ¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×ÐγÉÄÜÁ¦µÄ·½·¨¡£¸ü¾ßÌåµØËµ£¬Éæ¼°Ò»ÖÖ¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Èç¦Á-Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨¡£¸Ã·½·¨°üÀ¨½«´¿»¯µÄÖØ×éÈ˼²²¡Ïà¹Øµ°°×ÓëÊÜÊÔÕßÌåÒºÔÚÒ»¶¨Î¶ÈϽøÐÐÕñµ´·õÓý£¬È»ºóÀûÓÃÄܹ»¼ì²âÁ×ËữÐÞÊε°°×Öʵķ½·¨¼ì²â·õÓýºóµÄÌåÒºÖÐÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Èç¦Á-Í»´¥ºËµ°°×µÄº¬Á¿¡£
    ¡¾×¨Àû˵Ã÷¡¿Ò»ÖÖ¼ì²âÊÜʵÑéÕßÌåÒºÌåÍâ´Ù½ø¼²²¡Ïà¹Øµ°°×Á×ËữÐÞÊÎÄÜÁ¦µÄ·½·¨
    ¡¾¼¼ÊõÁìÓò¡¿:
    [0001]±¾·¢Ã÷Éæ¼°Ò»ÖÖ¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×ÐγÉÄÜÁ¦µÄ·½·¨£¬¸Ã·½·¨¿ÉÓÃÓÚÅÁ½ðÉ­²¡µÄÕï¶Ï¡£
    ¡¾±³¾°¼¼Êõ¡¿:
    [0002]ÅÁ½ðÉ­²¡ÊÇÒ»ÖÖ³£¼ûµÄÉñ¾­ÏµÍ³ÍËÐÐÐÔ¼²²¡£¬ÁÙ´²ÉÏÖ÷Òª±íÏÖΪ¾²Ö¹Õñ²ü¡¢Ô˶¯³Ù»º¡¢¼¡È⽩ֱºÍ×ËÊÆ²»Îȶ¨µÈÔ˶¯Ö¢×´(1£¬2)¡£ÒýÆðÕâЩ֢״µÄÔ­ÒòÊÇÖÐÄÔºÚÖʶà°Í°·Éñ¾­Ôª´óÁ¿ËÀÍöºÍÓÉ´ËÒýÆðµÄÎÆ×´Ì岿λµÄ¶à°Í°·Éñ¾­µÝÖʵĴó·ù¶È¼õÉÙ¡£ÅÁ½ðÉ­²¡µÄÖ÷Òª²¡ÀíÌØÕ÷ÊÇÉñ¾­Ï¸°ûÄÚ³öÏÖÊÈËáÐÔ°üº­Ìåһ·Ò×Ìå(Lewy body)ºÍ·Ò×Éñ¾­Ë÷(Lewyneurite)¡£¹¹³É·Ò×ÌåºÍ·Ò×Éñ¾­Ë÷µÄÖ÷Òª³É·ÖÊǦÁ-Í»´¥ºËµ°°×(a-synuclein) (3)¡£ÆäÖУ¬Ô¼90%µÄ¦Á-Í»´¥ºËµ°°×ΪÁ×ËữÐÞÊÎÐÎʽ(4)¡£´óÁ¿Ñо¿±íÃ÷£¬Á×ËữÐÞÊοɴٽø¦Á-Í»´¥ºËµ°°×µÄ¾ÛºÏ£¬´Ó¶øÔÚÅÁ½ðÉ­²¡µÄ·¢ÉúºÍ·¢Õ¹ÖÐÆð¹Ø¼üÐÔ×÷ÓÃ(5-9)¡£Òò´Ë£¬¼ì²âÁ×Ëữ¦Á-Í»´¥ºËµ°°×ÔÚÌåÒºÖеı仯±»ÈÏΪ¶ÔÅÁ½ðÉ­²¡¾ßÓÐÕï¶ÏÒâÒ塣ĿǰÑо¿±íÃ÷£¬ÅÁ½ðÉ­²¡ÈËѪҺÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×º¬Á¿Ôö¸ß£¬¶ø×ܦÁ-Í»´¥ºËµ°°×¼°¹Ñ¾Û»¯¦Á-Í»´¥ºËµ°°×ÔòÎ޴˸ıä(7£¬10)¡£Òò´Ë£¬Á×Ëữ¦Á-Í»´¥ºËµ°°×¿ÉÄܳÉΪһÖÖÅÁ½ðÉ­²¡Õï¶ÏµÄDZÔÚ±ê¼ÇÎȻ¶ø£¬ÓÉÓÚ¼ì²â¼¼ÊõµÄÏÞÖÆ£¬ÑªÒºÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×¼ì²âµÄÁéÃô¶È¼°ÌØÒì¶È½ÏµÍ¡£
    [0003]ÏÖÓм¼ÊõÖжÔѪҺÖÐÁ×Ëữ¦Á -Í»´¥ºËµ°°×¼ì²â·½·¨Ö÷ÒªÓÐ:ÀûÓÃELISA·½·¨Ö±½Ó¼ì²âÆäº¬Á¿¡£
    [0004]ÏÖÓз½·¨µÄȱÏÝÊÇ:»¼ÕߺͶÔÕյIJîÒì½ÏС£¬ºÜ¶àÊý¾ÝÖØµþ£¬ÄÑÒÔÓÃÓÚÁÙ´²¡£±¾·½·¨µÄÓÅÊÆ:Êý¾ÝÎȶ¨£¬»¼ÕߺͶÔÕÕ²îÒì½Ï´ó£»Ö÷Òª·´Ó³Ñª½¬´Ù½ø¦Á -Í»´¥ºËµ°°×Á×ËữµÄÄÜÁ¦¡£
    [0005]Ϊ¿Ë·þÉÏÊöȱÏÝ£¬±¾·¢Ã÷ÌṩһÖÖ¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Ðγɵķ½·¨£¬¸Ã·½·¨¾ßÓнϺõÄÎȶ¨ÐÔºÍÖØ¸´ÐÔ£¬¿ÉÒÔÏÔÖøÇø·ÖÅÁ½ðÉ­²¡È˺ÍÕý³£½¡¿µÈË£¬ÊÇÅÁ½ðÉ­²¡¸ßΣÈËȺɸѡ¡¢ÁÙ´²Õï¶Ï¼°²¡Çé¼à²âµÄÖØÒªÊֶΡ£

    ¡¾·¢Ã÷ÄÚÈÝ¡¿
    :
    [0006]±¾·¢Ã÷ÌṩһÖÖÅÁ½ðÉ­²¡µÄÕï¶Ï·½·¨£¬ÆäÖаüÀ¨¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Èç¦Á-Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨¡£
    [0007]±¾·¢Ã÷½«´¿»¯µÄÖØ×éÈ˼²²¡Ïà¹Øµ°°×ÓëÊÜÊÔÕßÌåÒºÔÚÒ»¶¨Î¶ÈϽøÐÐÕñµ´·õÓý£¬È»ºóÀûÓÃÊó¿¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå×÷Ϊ²¶»ñ¿¹Ì壬ÀûÓÃÉúÎïËØ»¯µÄÊó¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå×÷Ϊ¼ì²â¿¹Ì壬ÀûÓÿ¹Ô­-¿¹Ìå·´Ó¦Ô­Àí¼ì²âÅÁ½ðÉ­²¡È˺ÍÕý³£½¡¿µÈËÌåÒºÌåÍâ´Ù½ø¼²²¡Ïà¹Øµ°°×Á×ËữÐÞÊÎÐÎʽµÄÐγÉÄÜÁ¦²¢½øÐбȽÏ¡£
    [0008]±¾·¢Ã÷¼ì²âÊÜÊÔÕßÌåÒºÌåÍâ´Ù½øÁ×ËữÐÞÊεļ²²¡Ïà¹Øµ°°×Èç¼ì²â¦Á -Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨°üÀ¨ÒÔϲ½ÖèºÍÄÚÈÝ:[0009]I)·ÖÀëѪ½¬£»
    [0010]2)¼ÓÈëÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬µÃµ½Á×Ëữ¦Á -Í»´¥ºËµ°°×£»
    [0011]3)¿¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåºÍÁ×Ëữ¦Á-Í»´¥ºËµ°°×ÒÔ¼°¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå·õÓý£¬Ëæºó¼ÓÈë¼îÐÔÁ×ËáøºÍÏÔÉ«¼Á£¬½øÐÐÏÔÉ«£»
    [0012]4)Ó÷ֹâ¹â¶È·¨¶ÔÏÔÉ«µÄÑùÆ·½øÐÐÎü¹â¶È²â¶¨£¬¸ù¾Ý±ê×¼ÇúÏß¼ÆËãÑùÆ·ÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×µÄº¬Á¿¡£
    [0013]ÒÔ϶Ա¾·¢Ã÷ËùÓÃÃû³ÆÊõÓï½øÐнâÊÍ:
    [0014]ÖØ×éÈ˦Á -Í»´¥ºËµ°°×:½«Ð¯´øÈ˦Á -Í»´¥ºËµ°°×»ùÒòµÄÖÊÁ£×ªÈ¾ÖÁ´ó³¦¸Ë¾ú£¬ÅàÑø¡¢ÌáÈ¡²¢´¿»¯»ñµÃµÄÅÁ½ðÉ­²¡Ïà¹Øµ°°×¡£
    [0015]Á×Ëữ¦Á -Í»´¥ºËµ°°×:129λ˿°±Ëá·¢ÉúÁ×ËữÐÞÊεĦÁ -Í»´¥ºËµ°°×¡£
    [0016]¿¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå:¿¹Ô­Îªº¬129λÁ×ËữÐÞÊεÄË¿°±ËáÔÚÄÚµÄÈ˦Á-Í»´¥ºËµ°°×¶ÌëÄ£¬Æä°±»ùËáÐòÁÐΪGILEDMPVDTONEAYEMPSEEGYQDYEPEA£¬ÓëÁ鳤ÀදÎï·¢Éú·´Ó¦¡£±¾·¢Ã÷ʹÓõĿ¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåÃû³ÆÎª:4¦¥6¿¹Ìå,ΪÒÑÖª¿¹Ìå,ÊÇSanta cruz¹«Ë¾ËùÊÛµÄp-a-synuclein (Ser129)¿¹Ìå(»õºÅ:sc-135638)¡£
    [0017]¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå:3D5¿¹Ì壬ʶ±ð¦Á -Í»´¥ºËµ°°×µÚ115_121¸ö°±»ùËᣬ¿¹Ô­ÎªÈËÖØ×é¦Á-Í»´¥ºËµ°°×£¬ÓëÁ鳤ÀදÎï·¢Éú·´Ó¦¡£(¸Ã¿¹ÌåÒѾ­¹«¿ª£¬ÔÚ
    S.Yu, et al.Neuroscience, 145 (2007) 539-555ÖÐÒѾ­·¢±í,¿Éͨ¹ý¹ºÂòµÃµ½)¡£Ò²¿ÉÒÔ°´ÕÕÒÔÏ·½·¨ÖƱ¸:
    [0018]²½Öè1£¬µ°°×¿¹Ô­µÄÖÆ±¸:±¾ÊµÑéÊÒÖÆ±¸²¢´¿»¯ÈËÈ«³¤¦Á -Í»´¥ºËµ°°××÷Ϊ¿¹Ô­¡£
    [0019]²½Öè2£¬ÃâÒßСÊó£»Ê¹Óø£ÊÏÍêÈ«×ô¼Á(µÚÒ»´ÎÃâÒß)Ó븣Êϲ»ÍêÈ«×ô¼Á(ËæºóµÄÃâÒß)È黯È˦Á-Í»´¥ºËµ°°×£¬Ã¿¸ô2ÖܶÔBALB/c´ÆÐÔСÊó½øÐÐÃâÒß(50mg¿¹Ô­/ֻСÊó)¡£³éÈ¡¶¯ÎïѪÇ壬ÀûÓÃELISAÓëWestern blot·½·¨¼ì²âÆäЧ¼ÛÓëÌØÒìÐÔ¡£
    [0020]²½Öè3£¬ÓÃ3D5ÔÓ½»Áöϸ°û(¿É¹ºÂòµÃµ½)²úÉúÌØÐÔÐÔ¿¹Ìå¡£3D5ÔÓ½»Áöϸ°û¿ÉÒÔ²úÉúÌØÒìÐÔ¿¹È˦Á-Í»´¥ºËµ°°×¿¹Ìå¡£
    [0021]²½Öè4 ;¿¹ÌåÖÆ±¸:3D5ϸ°û´óÁ¿À©Ôö£¬²¢Óɸ¹Ä¤ÄÚ×¢ÉäÈëBALB/cÂãÊóÌåÄÚ£¬²úÉú¸¹Ë®£¬ºóÀûÓÃprotein AÇ׺ͲãÎö´¿»¯,µÃµ½3D5¿¹Ìå¡£
    [0022]¼îÐÔÁ×Ëáø:ÔÚELISA²â¶¨ÖУ¬¼îÐÔÁ×ËáøµÄɫԭµ×ÎïÊǶÔÏõ»ù±½Á×ËáÑÎ(p-nitropheny-phosate, ¦Ñ¦­¦±¦±)¡£¦Ñ¦­¦±¦±ÔÚ¼îÐÔÁ×ËáøµÄ×÷ÓÃÏÂÉú³É¶ÔÏõ»ùõª(pNP),ÆäÔÚÈë=405nm´¦ÓÐ×î´óÎüÊÕ¡£
    [0023]Ç׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø:½«¼îÐÔÁ×Ëáø½øÐÐÇ׺ÍËØ±ê¼Ç£¬Ç׺ÍËØ¿ÉÓëÉúÎïËØ½áºÏ£¬Æð¼¶Áª·Å´ó×÷Óá£
    [0024]ÏÔÉ«¼Á:Ïõ»ù±½Á×Ëáµ¥ÄÆÑΣ¬¿É¼ò³ÆÎª¦Ñ¦­¦±¦±µ¥ÄÆ¡£Óë¦Ñ¦­¦±¦± ¡ªÑù£¬ÓÃÓÚELISAµÄ»¯Ñ§ÏÔÉ«µ×Îï¡£¼îÐÔÁ×ËáøºÍPNPP·´Ó¦ºó£¬ÐγɻÆÉ«Ë®ÈÜ·´Ó¦²úÎ¸Ã²úÎïÔÚ405nm´¦ÓйâÎü¹â¡£
    [0025]ELISA ø±ê°å:ÔÚøÁªÃâÒßÎü¸½ÊÔÑé(Enzyme Linked ImmunosorbentAssay, ELISA)ÖУ¬×÷ÎªÔØÌåµÄ¹ÌÏà¾Û±½ÒÒÏ©(Polystyrene)±íÃæ¶Ô¿¹Ô­¡¢¿¹Ìå»ò¿¹Ô­¿¹Ì帴ºÏÎïµÄÎü¸½ÆðÖØÒª×÷Ó᣿¹Ô­¡¢¿¹ÌåºÍÆäËüÉúÎï·Ö×Óͨ¹ý¶àÖÖ»úÖÆÎü¸½ÖÁÔØÌå±íÃæ£¬Õâ°üÀ¨Í¨¹ýÊèË®¼ü¡¢Á÷Ë®/Àë×Ó¼üµÄ±»¶¯Îü¸½£¬Í¨¹ýÒýÈëÆäËü»îÐÔ»ùÍÅÈç°±»ùºÍ̼»ùµÄ¹²¼Û½áºÏ£¬ÒÔ¼°Í¨¹ý±íÃæ¸ÄÐÔºóµÄÇ×Ë®¼ü½áºÏ¡£
    [0026]PBS:‘zËỺ³åÒº(phosphate buffer solution),Ũ¶ÈΪ 0.01mol/L¡£
    [0027]NaHCO3»º³åÒº:̼ËáÇâÄÆ»º³åÒº£¬Å¨¶ÈΪ200mmol/L£¬PH9.6¡£
    [0028]·â±ÕÒº:Ã÷½ºº¬Á¿Îª2.5%µÄPBSTÈÜÒº£¬×÷ÓÃΪ·â±Õ·ÇÌØÒì½áºÏ£¬½µµÍELISA±³
    µ©
    -5^ O
    [0029]PBST:ÔÚ0.01mol/L PBSÖк¬ÓÐ0.05% Tween20¼´ÎªÁ×ËáÑÎÍÂλº³åÒº£¬PBST¡£
    [0030]±ê×¼ÇúÏßµÄÖÆ×÷·½·¨ÈçÏÂ:ÿ´ÎÊÔÑéʱ½«Á×Ëữ¦Á -Í»´¥ºËµ°°×ëĶνøÐÐϵÁÐÏ¡ÊÍ£¬ÖÕŨ¶È·Ö±ðΪ0.5,0.25,0.125,0.0625,0.03125¡¢0 ¦Ì mol/L£¬ÓëÑùƷͬʱ½øÐмì²â£¬¶ÁÈ¡Ïà¶ÔÓ¦405nm´¦Îü¹âÖµ£¬×ö³öÆäÓëŨ¶ÈÖ®¼äµÄ¹ØÏµÇúÏß¡£
    [0031]ÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5£¬ÆäÖÆ±¸·½·¨ÈçÏÂ:
    [0032]²½ÖèI£¬ÓÃÎÞË®DMSOÅäÖÆ10mg/mlÉúÎïËØN-ôÇ»ùçúçêõ£Ñǰ·õ¥ÈÜÒº¡£
    [0033]²½Öè2£¬ÓÃÅðËáÑλº³åÒº(0.lmol/L, pH8.8)Åä֯ō¶ÈÖÁÉÙΪI~3mg/mlµÄ¿¹Ìå3D5ÈÜÒº£¬Èô¿¹Ìå´¢´æÊ±¼ÓÈëÁ˵þµªÄÆ£¬Ôò±ê¼ÇǰÐëÏÈÔÚÅðËáÑλº³åÒºÖгä·Ö͸ÎöÒÔ³ýÈ¥µþµªÄÆ¡£ [0034]²½Öè3£¬°´25~100 ¦Ì g/mgµÄ±ÈÂʽ«ÉúÎïËØõ¥¼ÓÈ뿹Ìå3D5ÖУ¬»ìºÏ¾ùÔȲ¢ÔÚÊÒÎÂÏ·õÓý4h¡£
    [0035]²½Öè4£¬Ã¿250 ¦Ì gÉúÎïËØõ¥ÄÚ¼ÓÈë20 ¦Ì I lmol/LµÄÂÈ»¯ï§£¬ÊÒηõÓýlOmin¡£
    [0036]²½Öè5£¬½«¿¹Ìå3D5ÈÜÒºÓÃPBS»òÆäËûËùÐèµÄ»º³åҺ͸Îö£¬ÒÔ³ýȥδ½áºÏµÄÉúÎïËØ¡£
    [0037]²½Öè6£¬°´´¿»¯¿¹Ìå3D5µÄ´¢´æ·½·¨±£´æ±ê¼Ç¿¹Ìå3D5¡£
    [0038]ÓÅÑ¡µÄ±¾·¢Ã÷µÄ¼ì²â¦Á -Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨£¬²½ÖèÈçÏÂ:
    [0039]²½Öè1£¬
    [0040]È¡¾²ÂöѪ£¬±ØÒªÊ±¿ÉÒÔ¼ÓÈëEDTA¡¢¸ÎËØ»òèÛéÚËΌÄý£¬·ÖÀëѪ½¬²ã±¸Óã»
    [0041]²½Öè2£¬
    [0042]Ѫ½¬ÖмÓÈëÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬µÃµ½Á×Ëữ¦Á -Í»´¥ºËµ°°×£»
    [0043]²½Öè3£¬
    [0044]ELISAø±ê°åÖмÓÈ뿹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåºÍÁ×Ëữ¦Á -Í»´¥ºËµ°°×£¬ÒÔ¼°¿¹ÈË_¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå½øÐзõÓý£¬¼ÓÈëÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø£¬¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ£»
    [0045]²½Öè4£¬
    [0046]ÔÚ405nm´¦²â¶¨Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ£¬¸ù¾Ý±ê×¼ÇúÏß¼ÆËãÁ×Ëữ_ ¦Á -Í»´¥ºËµ°
    °×µÄº¬Á¿¡£
    [0047]ÌØ±ðÓÅÑ¡µÄ±¾·¢Ã÷µÄ¼ì²â¦Á -Í»´¥ºËµ°°×ÐγÉÄÜÁ¦µÄ·½·¨£¬²½ÖèÈçÏÂ:
    [0048]²½Öè1£¬
    [0049]Ѫ½¬µÄ·ÖÀë:
    [0050]³éÈ¡5-10ml¿¹ÄýѪ(EDTA¡¢¸ÎËØ»òèÛéÚËΌÄý)¡£½«¿¹ÄýѪÉÏϵߵ¹ÇáÇá»ìÔÈ£¬Ìù±Ú¼ÓÈëÖÁ50mlÀëÐĹÜÖУ¬¼Ç¼ȫѪµÄÌå»ý£¬1:1¼ÓÈëPBS£¬³ä·Ö»ìÔÈ¡£
    [0051]½«Ï¡ÊͺóµÄȫѪ»ºÂý¼ÓÖÁÁܰÍϸ°û·ÖÀëÒºÉÏ£¬400Xg£¬ÀëÐÄ20min¡£´Ëʱ¹ÜÄÚÒºÌåÓÉÉÏÖÁϵÄ˳ÐòÒÀ´ÎΪѪ½¬²ã¡¢°×Ĥ²ã(ÍâÖÜѪµ¥¸öºËϸ°û)¡¢·ÖÀëÒº²ãÒÔ¼°ºìϸ°û²ã¡£
    [0052]ÎüÈ¡±íÃæµÄѪ½¬²ã¡¢·Ö×°£¬_80¡ãC±£´æ±¸Óá£[0053]²½Öè2£¬
    [0054]Á×Ëữ¦Á -Í»´¥ºËµ°°×µÄÌåÍâÖÆ±¸:½«Ñª½¬ÓÃPBSÊʵ±Ï¡ÊÍ£¬¼ÓÈëÒ»¶¨Å¨¶ÈµÄÖØ×éÈ˦Á-Í»´¥ºËµ°°×£¬ÔÚºãÎÂÕñµ´Æ÷ÖÐ37¡ãCÕñµ´·õÓýÒ»¶¨Ê±¼ä£¬ÓÚ4¡ãC±£´æ±¸Óá£
    [0055]²½Öè3£¬
    [0056]°ü±»:ÓÃNaHCO3»º³åҺϡÊÍ¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåÖÁÖÕŨ¶ÈΪ
    0.1?I ¦Ì g/mL¡£Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬4¡ãC·õÓý¹ýÒ¹¡£ÓÃPBST (ÆäΪº¬ÓÐÍÂεÄPBS)³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0057]·â±Õ:Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L·â±ÕÒº(ÆäΪº¬ÓÐÃ÷½ººÍÍÂεÄPBS)£¬ÔÚ37¡ãC·õÓýI?2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0058]Ïò¸÷¿×¼ÓÈë100 ¦Ì LÒÑÖÆ±¸ºÃµÄÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÑùÆ·Ï¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI?2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0059]Ó÷â±ÕҺϡÊÍÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5¿¹ÌåÖÁÖÕŨ¶ÈΪ
    0.1?I ¦Ì g/mL¡£Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI?2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0060]Ó÷â±ÕҺϡÊÍÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø(ÓÉSigma¹«Ë¾³öÊÛ)£¬Ïòø±ê°åµÄ¸÷¿×¼ÓAlOOyL¸ÃøµÄÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓý0.5?2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0061]Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L ¦Ñ¦­¦±¦± (¶ÔÏõ»ùõªÁ×ËáÏÔɫҺ£¬ÓÉSigma¹«Ë¾³öÊÛ)£¬37¡ãCÏÔÉ«10?50·ÖÖÓ¡£
    [0062]²½Öè4£¬
    [0063]²â¶¨405nm´¦Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ¡£
    [0064]¸ù¾ÝÁ×Ëữ¦Á -Í»´¥ºËµ°°×±ê׼ƷŨ¶ÈÓë405nm´¦Îü¹âÖµÖ®¼äµÄ¹ØÏµÇúÏß¼ÆËãÊÜÊÔÕßѪҺÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×µÄÐγÉÁ¿¡£
    [0065]±¾·¢Ã÷¾­¹ýÑо¿·¢ÏÖ£¬ÉÏÊö·½·¨ÓëÏÖÓм¼ÊõÏà±È¾ßÓÐÈçÏÂÓŵã:
    [0066]Õï¶Ï׼ȷÐÔÌá¸ß£»
    [0067]Õï¶ÏÁéÃô¶È¼°ÌØÒì¶ÈÌá¸ß¡£
    [0068]ÒÔÏÂͨ¹ý±È½ÏÖ¤Ã÷±¾·¢Ã÷µÄÓŵã:
    [0069]Foulds PGµÈÈË2011ÄêµÄһƪÎÄÏ×±¨µ¼Ñª½¬ÖÐ×ÔÉíÁ×Ëữ¦Á -Í»´¥ºËµ°°×º¬Á¿¿É×÷ΪÅÁ½ðÉ­²¡Õï¶Ï±ê¼ÇÎ¸Ã·½·¨ROCÇúÏßÏÂÃæ»ýΪ0.68 £»Foulds PGµÈÈË2013ÄêÁíһƪ¹ØÓÚѪ½¬ÖÐ×ÔÉíÁ×Ëữ¦Á-Í»´¥ºËµ°°×º¬Á¿µÄ×ÝÏòÑо¿±¨µ¼£¬¸Ã·½·¨ROCÇúÏßÏÂÃæ»ýΪ
    0.717¡£¶ø±¾·¢Ã÷ROCÇúÏßÏÂÃæ»ý¿É´ï0.901£¬Õï¶Ï׼ȷÐÔÃ÷ÏÔ¸ßÓÚǰÕß¡£
    [0070]¸ù¾ÝÒÔÉÏÎÄÏ×±¨µ¼ÖеÄROCÇúÏ߿ɵóöÆä´óÖÂÁéÃô¶È¼°ÌØÒì¶È£¬·Ö±ðΪ0.6¼°
    0.75¡£¶ø±¾·½·¨ÁéÃô¶È¼°ÌØÒì¶È·Ö±ðΪ0.795¼°0.886£¬¿É¼û±¾·½·¨ÁéÃô¶È¼°ÌØÒì¶È¾ùÓÐÌáÎÅ¡£
    [0071]ÓÉÓÚ±¾·¢Ã÷Ч¹ûµÄÓÅÔ½ÐÔ£¬±¾·¢Ã÷È˸ù¾ÝÉÏÊö·½·¨ÖƱ¸ÁËÒ»ÖÖ¼ì²âÊÔ¼ÁºÐ£¬ËùÊöÊÔ¼ÁºÐ°üÀ¨ÒÔÏÂÊÔ¼Á:
    [0072]ÖØ×éÈ˦Á-Í»´¥ºËµ°°×
    [0073]¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå
    [0074]ÉúÎïËØ»¯¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå[0075]¸ù¾ÝÐèÒª£¬ËùÊöÊÔ¼ÁºÐ»¹¿É°üÀ¨ÒÔϸ¨ÖúÊÔ¼Á:
    [0076]¼îÐÔÁ×Ëáø£¬»òÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø
    [0077]¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ
    [0078]ELISA ø±ê°å
    [0079]PBS
    [0080]NaHCO3 »º³åÒº
    [0081]·â±ÕÒº
    [0082]PBST
    [0083]ÆäÖУ¬
    [0084]PBSµÄŨ¶ÈΪ0.01mol/L,ÅäÖÆ·½·¨Îª [0085]
    Na3HPCK2.72 g
    NaH2PCM0.28 g
    NaCI9 g
    DDWI 000 ml
    [0086]NaHCO3»º³åÒºµÄŨ¶ÈΪ200mmol/L£¬pH9.6£¬ÅäÖÆ·½·¨Îª
    [0087]NaHCO30.84g
    [0088]20% µþµªÄÆ(NaN3) 50 ¦Ì I
    [0089]DDff50ml
    [0090]·â±ÕÒºµÄŨ¶ÈΪ2.5%£¬ÅäÖÆ·½·¨Îª
    [0091]Ã÷½º2.5g
    [0092]PBST100mL
    [0093]PBST Ϊº¬ 0.05% Tween20 µÄ 0.0ImoI/L PBS£¬ÅäÖÆ·½·¨Îª
    [0094]
    Na2HPO42.72 g
    NaH3PO40.28 g
    NaCl9 g
    DDW1000 ml
    Twccn 20500 ¦ÌL
    [0095]ÉÏÊöÊÔ¼ÁºÐµÄʹÓÃÊÇÒÔѪ½¬ÖÐÁ×Ëữ-¦Á-Í»´¥ºËµ°°××÷Ϊ±ê×¼µ°°×£¬ÒÔÁ×Ëữ-¦Á-Í»´¥ºËµ°°×ÓëÎü¹â¶ÈÖµµÄ¹ØÏµÇúÏß×÷Ϊ±ê×¼ÇúÏߣ¬Í¨¹ý²â¶¨Ñù±¾ÖеÄÁ×Ëữ- ¦Á -Í»´¥ºËµ°°×µÄŨ¶ÈÒÔ¼°ÐγÉÂÊ´ïµ½Õï¶ÏÅÁ½ðÉ­²¡µÄÄ¿µÄ¡£
    [0096]±¾·¢Ã÷µÄÊÔ¼ÁºÐ£¬¸÷ÊÔ¼Á·Ö±ð°ü×°£¬ÓÅѡʹÓðü×°¹Ü£¬Ã¿¸ö°ü×°¹ÜÖÐ×°ÈëÊÔ¼ÁµÄÁ¿ÒÔ¹»Ò»¸öÑù±¾Ê¹ÓÃÁ¿Îª»ù±¾Á¿£¬¿ÉÒÔÀ©´óµ½10¸ö£¬100¸ö£¬1000¸öÑù±¾µÄʹÓÃÁ¿¡£
    [0097]±¾·¢Ã÷µÄÊÔ¼ÁºÐµÄʹÓÃÊǸù¾ÝÉÏÊö¼ì²âѪ½¬ÖÐÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µÄ·½·¨½øÐеģ¬Ê¹ÓÃʱ½«ÊÔ¼ÁºÐÖеÄÊÔ¼Á¸ù¾ÝÐèÒªÅäÖÆ³ÉÏàÓ¦µÄŨ¶È£¬°´ÕÕËùÊö·½·¨²â¶¨¼´¿É¡£
    [0098]ΪÑо¿±¾·¢Ã÷£¬»¹½øÐÐÁËÒÔÏÂÖØ¸´ÐÔÊÔÑ飬¾«ÃܶÈÊÔÑ飬¼ì²â·½·¨µÄɸѡµÈÊÔÑé[0099] ÏàͬÑù±¾Öظ´ÊµÑé3´Î£¬½á¹ûÏÔʾÏà¶Ô±ê×¼²îRSDΪ0.60%¡£
    [0100]½«ÊµÊ©Àý3ÖÐÖÆ±¸µÄÊÔ¼ÁºÐ·Ö±ðÈ¡ÈýÅú½øÐо«ÃܶÈʵÑé¡£ÒÔʵʩÀý3ÖÐËù³éÈ¡µÄÊÔ¼ÁºÐ²â¶¨Èý·Ý¸ß¡¢ÖС¢µÍÖµÑù±¾0.5ymol/L¡¢0.125 ¦Ì mol/LºÍ0.03125 ¦Ì mol/L¸÷8´Î¡£¼ÆËã²â¶¨Å¨¶ÈµÄ±äÒìϵÊý¡£ÊµÊ©Àý3ÖеÄÈýÅúÊÔ¼ÁºÐµÄ½á¹û±íÃ÷±äÒìϵÊýСÓÚ8.0%¡£
    [0101]²ÉÓÃÆåÅ̵ζ¨ÊÔÑéÈ·¶¨¿¹Ìå°ü±»Å¨¶ÈÒÔ¼°ÉúÎïËØ»¯¿¹ÌåŨ¶È¡£¸ù¾Ý³õ²½È·¶¨µÄŨ¶ÈËõС¼ä¾à£¬ÔÙ×ö½øÒ»²½ÆåÅ̵樣¬È·¶¨×î¼ÑÊÔÑéÌõ¼þ¡£×îÖÕÈ·¶¨°ü±»Å¨¶ÈΪ0.1~I ¦Ì g/mL,ÉúÎïËØ»¯¿¹ÌåŨ¶ÈΪ0.1~I ¦Ì g/mL¡£
    ¡¾×¨Àû¸½Í¼¡¿

    ¡¾¸½Í¼ËµÃ÷¡¿:
    [0102]ͼ1Ϊºìϸ°û·ÖÀë¹ý³ÌÖУ¬²»Í¬³É·Ö·Ö²ãʾÒâͼ¡£
    [0103]ͼ2Ϊ92Àý¶ÔÕÕÓëH)»¼ÕßѪ½¬ÖÐÁ×Ëữa -SynÐγÉÁ¿µÄELISA¼ì²â½á¹û¡£¡¾¾ßÌåʵʩ·½Ê½¡¿:
    [0104]ÒÔÏÂͨ¹ýʵʩÀý½øÒ»²½ËµÃ÷±¾·¢Ã÷¡£
    [0105]ʵʩÀý1£¬
    [0106]¾ßÌå²½ÖèÈçÏÂ:
    [0107](1)Ѫ½¬µÄ·ÖÀë:
    [0108].³éÈ¡5-10ml¿¹ÄýѪ(EDTA¡¢¸ÎËØ»òèÛéÚËΌÄý)¡£½«¿¹ÄýѪÉÏϵߵ¹ÇáÇá»ìÔÈ£¬Ìù±Ú¼ÓÈëÖÁ50mlÀëÐĹÜÖУ¬¼Ç¼ȫѪµÄÌå»ý£¬1:1¼ÓÈëPBS£¬³ä·Ö»ìÔÈ¡£
    [0109]?½«Ï¡ÊͺóµÄȫѪ»ºÂý¼ÓÖÁÁܰÍϸ°û·ÖÀëÒºÉÏ£¬400Xg£¬ÀëÐÄ20min¡£´Ëʱ¹ÜÄÚÒºÌåÓÉÉÏÖÁϵÄ˳ÐòÒÀ´ÎΪѪ½¬²ã¡¢°×Ĥ²ã(ÍâÖÜѪµ¥¸öºËϸ°û)¡¢·ÖÀëÒº²ãÒÔ¼°ºìϸ°û²ã¡£
    [0110].ÎüÈ¡±íÃæµÄѪ½¬²ã¡¢·Ö×°£¬-80¡ãC±£´æ±¸Óá£
    [0111](2)Á×Ëữ¦Á -Í»´¥ºËµ°°×µÄÌåÍâÖÆ±¸:½«Ñª½¬ÓÃPBSÊʵ±Ï¡ÊÍ£¬¼ÓÈëÒ»¶¨Å¨¶ÈµÄÖØ×éÈ˦Á-Í»´¥ºËµ°°×£¬ÔÚºãÎÂÕñµ´Æ÷ÖÐ37¡ãCÕñµ´·õÓýÒ»¶¨Ê±¼ä£¬ÓÚ4¡ãC±£´æ±¸Óá£
    [0112](3)°ü±»:ÓÃNaHCOj^³åҺϡÊÍ¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåÖÁÖÕŨ¶ÈΪ0.1~I ¦Ì g/mL¡£Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬4¡ãC·õÓý¹ýÒ¹¡£ÓÃPBST (ÆäΪº¬ÓÐÍÂεÄPBS)³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0113](4)·â±Õ:Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L·â±ÕÒº(ÆäΪº¬ÓÐÃ÷½ººÍÍÂεÄPBS)£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0114](5)Ïò¸÷¿×¼ÓÈë100 ¦Ì LÒÑÖÆ±¸ºÃµÄÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÑùÆ·Ï¡ÊÍÒº£¬ÔÚ37 V·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0115](6)Ó÷â±ÕҺϡÊÍÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5¿¹ÌåÖÁÖÕŨ¶ÈΪ0.1~I ¦Ì g/mL¡£Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0116](7)Ó÷â±ÕҺϡÊÍÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø(ÓÉSigma¹«Ë¾³öÊÛ)£¬Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸ÃøµÄÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓý0.5~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£
    [0117](8)Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì LpNPP(¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ£¬ÓÉSigma¹«Ë¾³öÊÛ)£¬37¡ãCÏÔÉ«10~50·ÖÖÓ¡£[0118](9)²â¶¨405nm´¦Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ¡£
    [0119](10)¸ù¾ÝÁ×Ëữ¦Á -Í»´¥ºËµ°°×±ê׼ƷŨ¶ÈÓë405nm´¦Îü¹âÖµÖ®¼äµÄ¹ØÏµÇúÏß¼ÆËãÊÜÊÔÕßѪҺÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×µÄÐγÉÁ¿¡£
    [0120]ʵʩÀý2£¬
    [0121 ] Ѫ½¬´Ù½ø¦Á -Í»´¥ºËµ°°×Á×ËữÐÞÊεÄÄÜÁ¦µÄ¼ì²â
    [0122]²ÉÓÃÏà¶Ô¶¨Á¿ELISA·¨£¬¶Ô44ÀýÁÙ´²Õï¶ÏµÄÅÁ½ðÉ­²¡È˺Í44Àý½¡¿µ¶ÔÕÕѪ½¬´Ù½ø¦Á-Í»´¥ºËµ°°×Á×ËữÐÞÊεÄÄÜÁ¦½øÐÐÁ˼ì²â¡£½á¹ûÏÔʾÅÁ½ðÉ­²¡ÈËѪ½¬ÖÐÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÐγÉÁ¿Îª68.2 ¦Ì mol/L ;¶øÕý³£½¡¿µ¶ÔÕÕѪ½¬ÖÐÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÐγÉÁ¿Îª41.6 ¦Ì mol/L¡£ÅÁÉ­²¡ÈËѪ½¬ÖÐÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÐγÉÁ¿Ã÷ÏÔ¸ßÓÚÕý³£½¡¿µ¶ÔÕÕ(P < 0.01)¡£
    [0123]ʵʩÀý3£¬
    [0124]ÊÔ¼ÁºÐ³É·Ö¾ÙÀý
    [0125]ÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬IOmg
    [0126]¿¹ÈËÁ×Ëữ-¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåIOyg
    [0127]ÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå10 ¦Ì g
    [0128]¼îÐÔÁ×Ëáø£¬»òÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø5 ¦Ì I
    [0129]¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺIOml
    [0130]ELISA ø±ê°å
    [0131]PBSlOml
    [0132]NaHCO3 »º³åÒº IOml
    [0133]·â±ÕÒº20ml
    [0134]PBST500ml
    [0135]ÒÔÏÂΪ²Î¿¼Îļþ:
    [0136]Reference List
    [0137](I) Lotharius J, Brundin P.Pathogenesis of Parkinson' sdisease: dopamine, vesicles and alpha-synuclein.Nat Rev Neurosci2002Dec £»3:932-942.[0138](2) Siderowf A, Stern M.Update on Parkinson disease.Ann InternMed2003Aprl5 £» 138:651-658.[0139](3) Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, GoedertM.Alpha-synuclein in Lewy bodies.Naturel997Aug28 £»388:839-840.[0140](4) Sato H, Kato T, Arawaka S.The role of Ser 129phosphorylation ofalpha-synuclein in neurodegeneration of Parkinson's disease:a review of in vivomodels.Rev Neurosci2013 £»24:115-123.[0141](5) Braithwaite SP, Stock JB, Mouradian MM.alpha-Synuc I e inphosphorylation as a therapeutic target in Parkinson' s disease.RevNeurosci2012 £»23:191-198.[0142](6) Fu j iwara H, Hasegawa M, Dohmae N, et al.alpha-Synuclein isphosphorylated in synucleinopathy lesions.Nat Cell Biol2002Feb ;4:160-164.[0143](7)Foulds PG£¬Mitchell JDj Parker A£¬et al.Phosphorylated alpha-synucleincan be detected in blood plasma and is potentially a useful biomarker forParkinson¡¯s disease.FASEB J2011Dec £»25:4127-4137.[0144](8)Hasegawa Mj Fujiwara H£¬Nonaka T£¬et al.Phosphorylated alpha-synucleinis ubiquitinated in alpha-synucleinopathy lesions.J Biol Chem2002Decl3 £»277:49071-49076.[0145](9)Cavallarin Nj Vicario M£¬Negro A.The role of phosphorylation insynucleinopathies: focus on Parkinson¡¯s disease.CNS Neurol Disord DrugTargets2010Aug ;9:471_481.[0146](10)Foulds P£¬Mann DM, Allsop D.Phosphorylated alpha-synuclein as apotential biomarker for Parkinson¡¯s disease and related disorders.Expert RevMol Diagn2012Mar ;12:115-117¡£
    ¡¾È¨ÀûÒªÇó¡¿
    1.Ò»ÖÖÓÃÓÚ¼ì²âÁ×ËữÐÞÊεĦÁ-Í»´¥ºËµ°°×º¬Á¿µÄÊÔ¼ÁºÐ£¬ÊÔ¼ÁºÐÖаüÀ¨ÒÔÏÂÊÔ¼Á:ÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ì壬¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå»òÉúÎïËØ»¯µÄ¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå¡£
    2.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÊÔ¼ÁºÐ£¬¸ù¾ÝÐèÒª£¬ËùÊöÊÔ¼ÁºÐ»¹¿É°üÀ¨ÒÔϸ¨ÖúÊÔ¼Á: ¼îÐÔÁ×Ëáø£¬»òÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø ¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ ELISAø±ê°å PBS NaHCO3»º³åÒº ·â±ÕÒº PBST¡£
    3.¸ù¾ÝȨÀûÒªÇó2ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÖÐ PBS µÄŨ¶ÈΪ 0.01mol/L, NaHCO3 »º³åÒºµÄŨ¶ÈΪ 200mmol/L£¬pH9.6£¬ ·â±ÕÒºµÄŨ¶ÈΪ2.5%£¬
    PBST Ϊº¬ 0.05% Tween-20 µÄ 0.01M PBS¡£
    4.¸ù¾ÝȨÀûÒªÇó2ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÖи÷ÊÔ¼Á·Ö±ð°ü×°£¬Ã¿¸ö°ü×°×°ÈëÊÔ¼ÁµÄÁ¿ÒÔ¹»Ò»¸öÑù±¾Ê¹ÓÃÁ¿Îª»ù±¾Á¿£¬¿ÉÒÔÀ©´óµ½10¸ö£¬100¸ö£¬1000¸öÑù±¾µÄʹÓÃÁ¿¡£
    5.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÊÔ¼ÁºÐ£¬ÆäÖп¹ÈËÁ×Ëữ¦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåΪ4E6¿¹Ìå¡£
    6.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÊÔ¼ÁºÐ£¬ËùÊö¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåΪ3D5¿¹Ìå¡£
    7.ÉúÎïËØ»¯µÄ¿¹È˦Á-Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5£¬ÆäÖÆ±¸·½·¨ÈçÏÂ: ²½Öè1£¬ÓÃÎÞË®DMSOÅäÖÆ10mg/mlÉúÎïËØN-ôÇ»ùçúçêõ£Ñǰ·õ¥ÈÜÒº¡£ ²½Öè2£¬ÓÃ0.lmol/L, pH8.8ÅðËáÑλº³åÒºÅä֯ō¶ÈΪI~3mg/mlµÄ¿¹Ìå3D5ÈÜÒº£¬Èô¿¹Ìå´¢´æÊ±¼ÓÈëÁ˵þµªÄÆ£¬Ôò±ê¼ÇǰÐëÏÈÔÚÅðËáÑλº³åÒºÖгä·Ö͸ÎöÒÔ³ýÈ¥µþµªÄÆ¡£ ²½Öè3£¬°´25~100 ¦Ì g/mgµÄ±ÈÂʽ«ÉúÎïËØõ¥¼ÓÈ뿹Ìå3D5ÖУ¬»ìºÏ¾ùÔȲ¢ÔÚÊÒÎÂÏ·õÓý4h¡£ ²½Öè4£¬Ã¿250 ¦Ì gÉúÎïËØõ¥ÄÚ¼ÓÈë20 ¦Ì I lmol/LµÄÂÈ»¯ï§£¬ÊÒηõÓýlOmin¡£ ²½Öè5£¬½«¿¹Ìå3D5ÈÜÒºÓÃPBS»òÆäËûËùÐèµÄ»º³åҺ͸Îö£¬ÒÔ³ýȥδ½áºÏµÄÉúÎïËØ¡£ ²½Öè6£¬°´´¿»¯¿¹Ìå3D5µÄ´¢´æ·½·¨±£´æ±ê¼Ç¿¹Ìå3D5¡£
    8.Ò»ÖÖÓÃȨÀûÒªÇó1µÄÊÔ¼ÁºÐ¼ì²âÁ×Ëữ¦Á-Í»´¥ºËµ°°×º¬Á¿µÄ·½·¨£¬°üÀ¨ÒÔϲ½Öè: (1)·ÖÀëѪ½¬£» (2)¼ÓÈëÖØ×éÈ˦Á-Í»´¥ºËµ°°×£¬µÃµ½Á×Ëữ¦Á-Í»´¥ºËµ°°×£» (3)¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåºÍÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÒÔ¼°¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå·õÓý£¬Ëæºó¼ÓÈë¼îÐÔÁ×ËáøºÍÏÔÉ«¼Á£¬½øÐÐÏÔÉ«£» (4)Ó÷ֹâ¹â¶È·¨¶ÔÏÔÉ«µÄÑùÆ·½øÐÐÎü¹â¶È²â¶¨£¬¸ù¾Ý±ê×¼ÇúÏß¼ÆËãÑùÆ·ÖÐÁ×Ëữ¦Á-Í»´¥ºËµ°°×µÄº¬Á¿¡£
    9.¸ù¾ÝȨÀûÒªÇó8ËùÊöµÄ·½·¨£¬²½ÖèÈçÏÂ:²½Öè1£¬ È¡¾²ÂöѪ£¬±ØÒªÊ±¿ÉÒÔ¼ÓÈëEDTA¡¢¸ÎËØ»òèÛéÚËΌÄý£¬·ÖÀëѪ½¬²ã±¸Óã» ²½Öè2£¬ Ѫ½¬ÖмÓÈëÖØ×éÈ˦Á -Í»´¥ºËµ°°×£¬µÃµ½Á×Ëữ¦Á -Í»´¥ºËµ°°×£» ²½Öè3£¬ ELISAø±ê°åÖмÓÈ뿹ÈËÁ×Ëữ- ¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåºÍÁ×Ëữ¦Á -Í»´¥ºËµ°°×£¬ÒÔ¼°¿¹ÈË_¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå½øÐзõÓý£¬¼ÓÈëÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø£¬¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ£» ²½Öè4£¬ ÔÚ405nm´¦²â¶¨Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ£¬¸ù¾Ý±ê×¼ÇúÏß¼ÆËãÁ×Ëữ_ ¦Á _Í»´¥ºËµ°°×µÄº¬Á¿¡£
    10.¸ù¾ÝȨÀûÒªÇó9ËùÊöµÄ·½·¨£¬²½ÖèÈçÏÂ: ²½Öè1£¬ Ѫ½¬µÄ·ÖÀë: ³éÈ¡5-10ml¿¹ÄýѪ(EDTA¡¢¸ÎËØ»òèÛéÚËΌÄý)¡£½«¿¹ÄýѪÉÏϵߵ¹ÇáÇá»ìÔÈ£¬Ìù±Ú¼ÓÈëÖÁ50mlÀëÐĹÜÖУ¬¼Ç¼ȫѪµÄÌå»ý£¬1:1¼ÓÈëPBS,³ä·Ö»ìÔÈ¡£ ½«Ï¡ÊͺóµÄȫѪ»ºÂý¼ÓÖÁÁܰÍϸ°û·ÖÀëÒºÉÏ£¬400Xg£¬ÀëÐÄ20min¡£´Ëʱ¹ÜÄÚÒºÌåÓÉÉÏÖÁϵÄ˳ÐòÒÀ´ÎΪѪ½¬²ã¡¢°×Ĥ²ã(ÍâÖÜѪµ¥¸öºËϸ°û)¡¢·ÖÀëÒº²ãÒÔ¼°ºìϸ°û²ã¡£ ÎüÈ¡±íÃæµÄѪ½¬²ã¡¢·Ö×°£¬_80¡ãC±£´æ±¸Óᣠ²½Öè2£¬ Á×Ëữ¦Á-Í»´¥ºËµ°°×µÄÌåÍâÖÆ±¸:½«Ñª½¬ÓÃPBSÊʵ±Ï¡ÊÍ£¬¼ÓÈëÒ»¶¨Å¨¶ÈµÄÖØ×éÈ˦Á-Í»´¥ºËµ°°×£¬ÔÚºãÎÂÕñµ´Æ÷ÖÐ37¡ãCÕñµ´·õÓýÒ»¶¨Ê±¼ä£¬ÓÚ4¡ãC±£´æ±¸Óᣠ²½Öè3£¬ °ü±»:ÓÃNaHCOj^³åҺϡÊÍ¿¹ÈËÁ×Ëữ-¦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹ÌåÖÁÖÕŨ¶ÈΪ0.1~I ¦Ì g/mL¡£Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬4¡ãC·õÓý¹ýÒ¹¡£ÓÃPBST (ÆäΪº¬ÓÐÍÂεÄPBS)³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ ·â±Õ:Ïòø±ê°å¸÷¿×¼ÓÈë100 ¦Ì L·â±ÕÒº(ÆäΪº¬ÓÐÃ÷½ººÍÍÂεÄPBS)£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ Ïò¸÷¿×¼ÓÈë100 ¦Ì LÒÑÖÆ±¸ºÃµÄÁ×Ëữ¦Á -Í»´¥ºËµ°°×ÑùÆ·Ï¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ Ó÷â±ÕҺϡÊÍÉúÎïËØ»¯µÄ¿¹È˦Á -Í»´¥ºËµ°°×µ¥¿Ë¡¿¹Ìå3D5¿¹ÌåÖÁÖÕŨ¶ÈΪ0.1~I ¦Ì g/mL¡£Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸Ã¿¹ÌåÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓýI~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ Ó÷â±ÕҺϡÊÍÇ׺ÍËØ±ê¼ÇµÄ¼îÐÔÁ×Ëáø£¬Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L¸ÃøµÄÏ¡ÊÍÒº£¬ÔÚ37¡ãC·õÓý0.5~2Сʱ¡£ÓÃPBST³åϴø±ê°å¸÷¿×£¬¸ù¾ÝÐèҪȷ¶¨³åÏ´´ÎÊýºÍʱ¼ä¡£ Ïòø±ê°åµÄ¸÷¿×¼ÓÈë100 ¦Ì L ¦Ñ¦­¦±¦± (¶ÔÏõ»ù·ÓÁ×ËáÏÔɫҺ)£¬37¡ãCÏÔÉ«10~50·ÖÖÓ¡£ ²½Öè4£¬ ²â¶¨405nm´¦Ã¸±ê°å¸÷¿×µÄÎü¹â¶ÈÖµ¡£ ¸ù¾ÝÁ×Ëữ¦Á -Í»´¥ºËµ°°×±ê׼ƷŨ¶ÈÓë405nm´¦Îü¹âÖµÖ®¼äµÄ¹ØÏµÇúÏß¼ÆËãÊÜÊÔÕßѪҺÖÐÁ× Ëữ¦Á-Í»´¥ºËµ°°×µÄÐγÉÁ¿¡£
    ¡¾Îĵµ±àºÅ¡¿G01N33/577GK103954763SQ201410193762
    ¡¾¹«¿ªÈÕ¡¿2014Äê7ÔÂ30ÈÕ ÉêÇëÈÕÆÚ:2014Äê5ÔÂ8ÈÕ ÓÅÏÈȨÈÕ:2014Äê5ÔÂ8ÈÕ
    ¡¾·¢Ã÷Õß¡¿ÓÚ˳, ÒüÄÈ, ÑîΡΡ, Àîê¿ ÉêÇëÈË:Ê×¶¼Ò½¿Æ´óѧÐûÎäÒ½Ôº

    • רÀûÃû³Æ£ºÒ»ÖÖ²ÉÓøßЧҺÏàÉ«Æ×¼ì²â¹¦ÄÜÆ¡¾ÆÖÐÅ£»ÇËáµÄ·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷ÊôÓÚÆ¡¾ÆÖÊÁ¿ÆÀ¼Û¼¼ÊõÁìÓò£¬¸üÏêϸµØËµ£¬Éæ¼°ÓÃÓÚ¼ì²â¹¦ÄÜÆ¡¾ÆÖÐÅ£»Ç ËáµÄ¸ßЧҺÏàÉ«Æ×·¨¡£±³¾°¼¼Êõ£ºÅ£»ÇËá(Taurine)ÊÇÒ»Öֹ㷺´æÔÚÓÚÈ˺Ͷ¯ÎïÌåÄڵĺ¬Áò£¿°±»ùËᣬÔçÔÚ
    • רÀûÃû³Æ£º¼ìÑ鯽°åÉÏÓÿɵ÷½ÚÒÆ¶¯Ê½¸Ü¸Ë°Ù·Ö±í¼Ü¼°ÆäʹÓ÷½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°Ò»ÖÖ¼ìÑé×°Öã¬ÌØÖ¸Ò»ÖÖ¼ìÑ鯽°åÉÏÓÿɵ÷½ÚÒÆ¶¯Ê½¸Ü¸Ë°Ù·Ö±í¼Ü£¬Ö÷ÒªÓÃÓڼгָܸ˰ٷֱíÔÚ¼ìÑ鯽°åÉϼì²â¼Ó¹¤Áã¼þµÄƽÐжÈ¡£±³¾°¼¼Êõ£º²ñÓÍ»úµÄµ÷ËÙÆ÷·É´¸ÊÇÒ»ÖÖÒìÐÎÁã¼þ£¬Íâ
    • רÀûÃû³Æ£ºÒ»ÖÖÀ­Å¤ÊÔ¼þ¼Ð¾ßµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°Ò»ÖÖÀ­Å¤ÊÔÑé»ú£¬ÓÈÆäÉæ¼°Ò»ÖÖÀ­Å¤ÊÔÑé»úÖеÄÊÔ¼þºÍ¼Ð¾ß£¬ÊôÓÚ²ÄÁÏÁ¦Ñ§ÊÔÑé»ú¼¼ÊõÁìÓò¡£±³¾°¼¼Êõ£ºÔÚ½ðÊô²ÄÁÏÁ¦Ñ§ÊµÑéÁìÓòÀÀ­Å¤ÊÔÑéÊǸöÐÂÉúÊÂÎÏÖÓеÄÀ­Å¤ÊµÑéŤ¾Ø¶¼ÔÚ50N ¡¤ mÒÔÏ£¬¿É
    • רÀûÃû³Æ£ºÉúÎïÌåÐÅÏ¢²â¶¨×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°Ò»ÖÖÉúÎïÌåÐÅÏ¢²â¶¨×°Öã¬Æä°üÀ¨Ö÷Ìå×°Öã¬Æä¾ß±¸ÔØÖò¿ºÍ½Å²â¶¨²¿£¬ÔÚÔØÖò¿ÉÏÔØÖÃÓû§µÄ½Å£¬½Å²â¶¨²¿±»ÉèÖÃÔÚÔØÖò¿ÉÏ£¬²â¶¨Óû§µÄÉúÎïÌåÐÅÏ¢£»ÒÔ¼°°Ñ³Ö×°Öã¬Æä¾ß±¸ÏÔʾ²¿£¬ÏÔʾ²¿ÏÔʾÓɽŲⶨ
    • רÀûÃû³Æ£ºÓÃÓÚͬÖá¶È²âÁ¿µÄÁª¶¯½á¹¹¼°Í¬Öá¶È²âÁ¿×°ÖõÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°»úе¼¼ÊõÁìÓò£¬ÓÈÆäÉæ¼°Ò»ÖÖÓÃÓÚͬÖá¶È²âÁ¿µÄÁª¶¯½á¹¹¼°Í¬Öá ¶È²âÁ¿×°Öᣱ³¾°¼¼Êõ£ºÄ¿Ç°£¬Ðýת²¿¼þ»òÆðÖá³ÐÖ§³Å×÷ÓõIJ¿¼þ×÷Ϊ»úе½á¹¹µÄÖØÒª×é³É£¬ÆäͬÖá¶ÈµÄ ºÃ»µ
    • רÀûÃû³Æ£ºÒ»Öֺ˴ʲÕñ´ÅÌåÍâ¿Ç×°Åä¼ìÑ鹤װµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°×°Åä¼ìÑ鹤װ£¬ÌرðÊǺ˴ʲÕñ´ÅÌåÍâ¿ÇµÄ×°Åä¼ìÑ鹤װ¡£ ±³¾°¼¼Êõ£ººË´Å¹²ÕñMRÊÇ´óÐ͵ÄҽѧӰÏñÉ豸£¬ÒòÆäÕï¶ÏͼÏñ¶ÔÈËÌåÈí×éÖ¯ÉϾßÓÐÃ÷ÏÔµÄÓÅÊÆ£¬²¢ÇÒÏà¶ÔÓÚXÉäÏßÕï¶ÏͼÏñ
    ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾
    È«¹ú·þÎñÈÈÏߣº13062023238
    µç»°£º13062023238
    µØÖ·£ºëøÖÝÊÐÁúȪ¹¤ÒµÔ°68ºÅ
    ¹Ø¼ü´Ê£ºÏ³´²£¬Êý¿ØÏ³´²£¬ÁúÃÅϳ´²
    ¹«Ë¾¶þάÂë
    Copyright 2010-2024 °æÈ¨ËùÓÐ All rights reserved ³ICP±¸19044495ºÅ-12

    ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿